The store will not work correctly when cookies are disabled.
5-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-3-hydroxy-4-methoxy-5H-furan-2-one
ID: ALA45237
PubChem CID: 14351106
Max Phase: Preclinical
Molecular Formula: C10H14O6
Molecular Weight: 230.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC1=C(O)C(=O)OC1C1COC(C)(C)O1
Standard InChI: InChI=1S/C10H14O6/c1-10(2)14-4-5(16-10)7-8(13-3)6(11)9(12)15-7/h5,7,11H,4H2,1-3H3
Standard InChI Key: IRFTYLPNPVDEBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
6.3667 -3.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5542 -3.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3417 -2.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6667 -3.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -2.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -2.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2667 -1.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4417 -1.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2292 -2.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 -3.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4667 -2.8000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7792 -4.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 -4.4542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6417 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -1.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3292 -4.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 1 1 0
5 4 1 0
6 3 1 0
7 6 1 0
8 7 1 0
9 10 1 0
10 6 1 0
11 4 2 0
12 1 1 0
13 2 1 0
14 8 1 0
15 8 1 0
16 13 1 0
5 3 1 0
8 9 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 230.22 | Molecular Weight (Monoisotopic): 230.0790 | AlogP: 0.48 | #Rotatable Bonds: 2 |
Polar Surface Area: 74.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.25 | CX Basic pKa: ┄ | CX LogP: -0.10 | CX LogD: -0.16 |
Aromatic Rings: ┄ | Heavy Atoms: 16 | QED Weighted: 0.70 | Np Likeness Score: 1.91 |
References
1. Abell AD, Ratcliffe MJ, Gerrard J.. (1998) Ascorbic acid-based inhibitors of alpha-amylases., 8 (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4] |
2. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J.. (2015) From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors., 23 (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007] |